Donovan Quill | EVP of Life Science Strategies
AscellaHealth

Donovan Quill is the Executive Vice President of Life Science Strategies at AscellaHealth, a global leader in healthcare and specialty pharmacy solutions serving patients, manufacturers, payers and providers. Overseeing sales planning, new channel development, lead generation, and strategic partnerships, he plays a pivotal role in supporting the organization’s mission to advance the future of specialty healthcare and enhance quality of life for patients with complex, chronic conditions. Donovan has over 20 years of experience, with 15 years in the healthcare sector, managing all aspects of operations, product launches and strategic planning. His primary focus is on the needs of patients and their caregivers, alongside healthcare providers and product manufacturers. As a cofounder, President and CEO of Optime Care, Donovan helped develop initiatives to streamline specialty pharmaceutical access and enhance the delivery of personalized patient care. P r i o r t o t h a t , h e held the position of Senior Vice President of Patient Direct Programs and was the Vice President of Patient Services at Centric Health Resources, which is now part of Eversana. Donovan also worked as a Specialty Sales Representative for Talecris Biotherapeutics, now known as Grifols. Before joining Talecris, Donovan served as an Alpha-1 Patient Advocate, where he focused on raising awareness, improving detection, and educating both patients and healthcare providers. The Alpha-1 Foundation subsequently recruited him to serve as the Director of Detection and Community Outreach. Donovan holds a bachelor’s degree in Criminal Justice/Law Enforcement Administration from DeSales University.